Search
Close this search box.

Cybersecurity Workshops

Get exclusive access to our Cybersecurity Workshops and learn about staying ahead of emerging trends in cyber defense!

Lyell Immunopharma Improves Cloud Security with Fidelis Security

Lyell Immunopharma is a South San Francisco-based, publicly traded cell therapy company (LYEL). Their T cell reprogramming technology focuses on the mastery of T cells to cure patients with solid tumors. They apply proprietary genetic and epigenetic reprogramming technology platforms to address barriers present in solid tumors in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.

Filter by Product:

Select
  • Taking Down Nation State Botnets

    Join security experts for real-world insights, examples, and strategies to...

    Read Workshop